A Cross‐Study Analysis Evaluating - Wiley Online Library

Details: Phase 3 AF Study. The ROCKET AF study (Rivaroxaban Once-daily oral direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) was a prospective, randomized, double-blind, double-dummy, parallel-group, active-controlled, multicenter, event-driven phase 3 study that compared the efficacy …

› Verified 3 days ago

› Url: accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.958 Go Now

› Get more:  StudyView Study

Source link